Rebecca Luse's most recent trade in LB Pharmaceuticals Inc was a trade of 22,449 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LB Pharmaceuticals Inc | Rebecca Luse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 22,449 | 22,449 | - | - | Stock Option (Right to Buy) |